Eyeworld Supplements

ASCRS Clinical Survey 2017

This is a supplement to EyeWorld Magazine.

Issue link: https://supplements.eyeworld.org/i/890857

Contents of this Issue

Navigation

Page 13 of 15

14 • 2017 ASCRS Clinical Survey " " Key findings Overall, respondents reported that 8% of their cataract patients are referred to retinal specialists. Nearly 80% of those surveyed (78%) are confident or very confident in their understanding of anti-VEGF treatments on cataract patients. I think OCT is essential in all preop cataract patients, and a retinal examination should be performed using an indirect ophthalmoscope. When it comes to anti-VEGF treatments, clinical trials have shown not all drugs are created equal in terms of outcomes. What's more, real-world experience data has shown that patients often receive an insufficient number of anti-VEGF injections because of prolonged treatment intervals; clinical trials have shown that across all diseases more injections drive better outcomes. Steve Charles, MD, chair, Retina Clinical Committee Retina Retina

Articles in this issue

Archives of this issue

view archives of Eyeworld Supplements - ASCRS Clinical Survey 2017